Thermo Fisher Scientific acquires Clario
Thermo Fisher Scientific agreed to acquire Clario. Reported deal value: $9.4B. Status: Pending. Sector: Not specified. Target headquarters context: Philadelphia, Pennsylvania, United States.
This page summarizes publicly available information about the transaction as of 2026-02-10. Figures and status may change as filings and press coverage update.
Thermo Fisher Scientific Inc. , a life science and clinical research company, on Tuesday announced it has priced a $3.8 billion senior notes offering to partially fund its pending acquisition of Clario Holdings , Inc
Deal timeline
This transaction is classified in Internet Service Providers, Web Search Portals, and Data Processing Services (518) with a reported deal value of $9.4B. Figures and status may change as sources update.